Related Experiment Video
Updated: May 15, 2026

Predictive Immune Modeling of Solid Tumors
Published on: February 25, 2020
Predictive value of clinical judgment of tumour progression in phase II trials
Nuria Kotecki1, Nicolas Penel, Antoine Adenis
1Centre Oscar Lambret, Lille, France.
Background:
The diagnosis of tumour progression or progressive disease (PD) is a key element for designing and interpreting contemporary phase II trials. In some cases, PD is stated by the physician and is not formally confirmed by imaging.
Purpose:
In this study, we intend to analyze the value of the PD based on clinical judgment and the risk of overestimating the occurrence of PD by clinical judgment.
Methods:
We have conducted a single-centre retrospective study to analyse the diagnostic accuracy of this clinical judgment compared to planned imaging including all patients enrolled in our institution in phase II trials investigating systemic treatments for advanced solid tumours between January 2008 and November 2010.
Results:
The positive predictive value (PPV) and the specificity of clinical judgment of PD was very high (>90%).
Conclusions:
According to this study, the clinical judgment of PD is highly predictive of radiological PD as assessed, for example, by RECIST. Physicians do not overestimate PD occurence. Clinical judgment of PD could be taken into account in the definition of PD.
Related Concept Videos
Clinical Trials: Overview
Clinical Trials
There are four phases in a clinical trial. A phase one...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Sensitivity, Specificity, and Predicted Value
Sensitivity is the...
Cancer Survival Analysis